FDA NDC Directory · JSON-LD · Markdown

Coxsackie A2, A7, B1, B3, B4, B5 Nosodes

NDC 43742-2571 · DRUG FOR FURTHER PROCESSING · LIQUID

Labeler / ManufacturerDeseret Biologicals
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeLIQUID
Active ingredientsHUMAN COXSACKIEVIRUS A2 (1 [hp_M]/mL)
HUMAN COXSACKIEVIRUS A7 (1 [hp_M]/mL)
HUMAN COXSACKIEVIRUS B1 (1 [hp_M]/mL)
HUMAN COXSACKIEVIRUS B3 (1 [hp_M]/mL)
HUMAN COXSACKIEVIRUS B4 (1 [hp_M]/mL)
HUMAN COXSACKIEVIRUS B5 (1 [hp_M]/mL)
Marketing started20261029
Package count1

External sources

Source: openFDA. Public-domain (CC0).